Casdin Capital, LLC 13D and 13G filings for Standard BioTools Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-03-04 7:46 pm Purchase | 2025-02-28 | 13D | Standard BioTools Inc. LAB | Casdin Capital, LLC | 80,864,315 21.600% | 7,098,241 (+9.62%) | Filing |
| 2024-08-14 8:54 pm Purchase | 2024-08-12 | 13D | Standard BioTools Inc. LAB | Casdin Capital, LLC | 73,766,074 19.770% | 3,364,737 (+4.78%) | Filing |
| 2024-06-03 5:20 pm Sale | 2024-05-30 | 13D | Standard BioTools Inc. LAB | Casdin Capital, LLC | 70,401,337 18.910% | -5,936,401 (-7.78%) | Filing |
| 2024-05-22 4:54 pm Purchase | 2024-05-17 | 13D | Standard BioTools Inc. LAB | Casdin Capital, LLC | 76,337,738 20.370% | 1,802,072 (+2.42%) | Filing |
| 2024-03-20 5:25 pm Purchase | 2024-03-18 | 13D | Standard BioTools Inc. LAB | Casdin Capital, LLC | 74,535,666 19.250% | 9,238,070 (+14.15%) | Filing |
| 2024-01-09 5:13 pm Purchase | 2024-01-05 | 13D | Standard BioTools Inc. LAB | Casdin Capital, LLC | 65,297,596 19.710% | 27,715,250 (+73.75%) | Filing |
| 2022-04-08 5:07 pm Purchase | 2022-04-04 | 13D | Standard BioTools Inc. LAB | Casdin Capital, LLC | 37,582,346 32.740% | 37,582,346 (New Position) | Filing |